Pfizer reports data on 3-dose COVID-19 vaccine for children under five
Pfizer reports data on 3-dose COVID-19 vaccine for children under five
In long-awaited data, Pfizer said its three-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old.WATCH FULL EPISODES OF WORLD NEWS TONIGHT:
https://abc.com/shows/world-news-tonight
WATCH WORLD NEWS TONIGHT ON HULU:
https://bit.ly/3iQLwPp
#WorldNewsTonight #Pfizer #Covid-19 #ChilderUnder5
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.